Periodic Paralysis Report - Dante Labs

Periodic Paralysis Report

Regular price €49.00 EUR

Please note that these reports are recommended only for Whole Genome Test with 30X and up coverage

(Not compatible with WGL Longreads sequencing test)


Periodic Paralysis is a rare genetic disorder. It causes sudden attacks of short-term muscle weakness, stiffness, or paralysis.

The Periodic Paralysis Report is based on Whole Genome Sequencing Test. As such, it analyses all Common and Rare Variants associated with Periodic Paralysis. Hypokalemic Periodic Paralysis (HypoPP) is one of the periodic paralysis conditions; autosomal dominant genetic disorders caused by mutations in the sodium, potassium, and calcium channel genes in the skeletal muscle. In general, HypoPP is characterised by reversible attacks of muscle weakness coupled with decreased blood potassium concentrations.

Along with environmental factors, Genetics plays a key role in the regulation of Periodic Paralysis.


Click here  to see what your report will look like


  • 98 genes analyzed
  • 100% genomic regions covered
  • Intragenic and intergenic regions analyzed
  • All variants reported



List of genes:


We use a cutting-edge form of technology that not even the most advanced hospitals can provide and that allows us to sequenced your entire DNA with unparalleled precision, instead of focusing on only small parts of the DNA. 
Our Sequencing Center is located in L'Aquila, Italy, and with its 900 square-meter fully dedicated to Whole Genome Sequencing is considered Europe's largest private NGS laboratory. 

We perform all our analysis internally and thanks to our high-throughput next generation sequencing (NGS) equipment we guarantee superior quality.

Your sample and data will stay in the European Union (also if you are a US resident) and is protected by the EU General Data Protection Regulation (GDPR). Our technology offers data protection improvements not required by law but considered best practices in the industry.